topic covers development and market status of drugs, devices and overall clinical management of obesity; excludes coverage of over the counter, consumer-oriented weight loss products
The market for tissue engineering and cell therapy products is set to grow to nearly $32 billion by 2018. This figure includes bioengineered products that are themselves cells or are actively stimulating cell growth or regeneration, products that often represent a combination of biotechnology, medical device and pharmaceutical technologies. The largest segment in the overall [...]
Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence. (PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of [...]
Technologies that destroy tissue for therapeutic benefit are collectively known as ablation technologies. By a wide range of energy types or other mechanical methods, they are used to destroy, excise or otherwise treat tissue for therapeutic benefit, from the radiation of cancer, the destruction of the endometrial lining of the uterus causing endometriosis, the creation [...]
The applications of energy-based technologies for the ablative treatment of tissue are numerous and diverse as a result of the effectiveness of these technologies — which vary widely by energy type (electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet/hydrotherapy, microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation) — and their integration into routine [...]
PRLog (Press Release) – Jun 09, 2010 – The practice of surgery has long employed energy-based technologies to excise, cut, ablate, cauterize, destroy or otherwise manipulate tissue to produce therapeutic results. Various energy modalities — from cryotherapy to microwave to radiofrequency to ultrasound to radiation and others — have proven their ability to effect healthy or diseased tissue [...]
Energy-based ablation devices are powered by a wide variety of sources, resulting in a plethora of devices. These include electrical, radiation, light, radiofrequency, ultrasound, cryotherapy, thermal, microwave and hydromechanical. This array of technology enables the physician, with the appropriate device in hand, to pinpoint and destroy almost any kind of tissue, almost anywhere in the [...]
The applications of surgical sealants, glues and wound closure are many and are rapidly multiplying as more credible data is generated on each application and as physicians gain comfort in working with the products in routine clinical practice. Below is a sample of surgical sealants, glues and wound closure applications by clinical area: Source: [...]
Looking at the course of developments — in the healthcare reform "debate" (as it were) and medical technology — it is not a huge leap of judgment to make the following predictions for the ups and downs of healthcare overall and for specific medical technologies. Predictions for the healthcare market A healthcare reform package will [...]
In cardiovascular and spine surgery, multi-billion dollar markets were created from entirely new procedures between 1980 and 2000, with subsequent segmentation in later years particularly as new minimally invasive procedures were developed towards the end of the 20th century. In the cardiovascular arena, the development of new procedures for angioplasty and bypasses in the late [...]
Below is a sampling of recently identified medical technology startups, identified in 2009 (drawn from the Medtech Startups Database). Company Product/technology QFX Technologies, Inc. External fixation for leg bone fractures. Axis Surgical Technologies, Inc. Devices for minimally invasive spine surgery NuOrtho Surgical, Inc. Radiofrequency preservation of tissues during orthopedic surgery Selecta Biosciences, Inc. [...]
Contact:
